Clinical and Experimental Evidences of Hydrogen Sulfide Involvement in Lead-Induced Hypertension

Abstract

Lead- (Pb-) induced hypertension has been shown in humans and experimental animals and cardiovascular effects of hydrogen sulfide (H2S) have been reported previously. However, no studies examined involvement of H2S in Pb-induced hypertension. We found increases in diastolic blood pressure and mean blood pressure in Pb-intoxicated humans followed by diminished H2S plasmatic levels. In order to expand our findings, male Wistar rats were divided into four groups: Saline, Pb, NaHS, and Pb + NaHS. Pb-intoxicated animals received intraperitoneally (i.p.) 1st dose of 8 μg/100 g of Pb acetate and subsequent doses of 0.1 μg/100 g for seven days and sodium hydrosulfide- (NaHS-) treated animals received i.p. NaHS injections (50 μmol/kg/twice daily) for seven days. NaHS treatment blunted increases in systolic blood pressure, increased H2S plasmatic levels, and diminished whole-blood lead levels. Treatment with NaHS in Pb-induced hypertension seems to induce a protective role in rat aorta which is dependent on endothelium and seems to promote non-NO-mediated relaxation. Pb-intoxication increased oxidative stress in rats, while treatment with NaHS blunted increases in plasmatic MDA levels and increased antioxidant status of plasma. Therefore, H2S pathway may be involved in Pb-induced hypertension and treatment with NaHS exerts antihypertensive effect, promotes non-NO-mediated relaxation, and decreases oxidative stress in rats with Pb-induced hypertension.

Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?

“…The role of H 2 S in vascular diseases, inflammation, critical illness, reperfusion injury, various nervous system diseases, metabolic diseases and cancer was extensively reviewed [ 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 ]. Evidence in support of a role of H 2 S deficiency in vascular disorders, such as hypertension and atherosclerosis, is accumulating [ 79 , 80 ]. Other review articles addressed the vascular biology of H 2 S and the mechanisms of HHCy-induced vascular injury [ 81 , 82 ].…”

Increase of Homocysteinemia/Hydrogen Sulfide (Hcy/H2S) Ratio Raises Cardiovascular Injuries

“…Consequently, an increased Hcy/H 2 S ratio comes, for increase of the numerator and decrease of the denominator. In this condition vascular injuries especially happen, because vascular derangements [10,57] are added to the vascular injuries (due to H 2 S deficiency) [21,58]. Thus, the Hcy/H 2 S ratio can be considered as a biomarker able to induce vascular injuries more than HHcy and H 2 S deficiency esteemed separately.…”

Hydrogen sulfide: A new therapeutic target in vascular diseases

“…Several clinical studies have reported the relationship between H 2 S and hypertension related disorders ( 13 ). Additionally, decreased H 2 S plasmatic levels were also found in lead-induced HBP patients ( 14 ).…”